Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Randomized, Placebo Controlled Study of the Efficacy and Safety of Three Doses of Orvepitant in Subjects With Chronic Refractory Cough

NCT02993822 is registered in ClinicalTrials.gov with Nerre Therapeutics Ltd. as lead sponsor.

NCT NCT02993822
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02993822 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Randomized, Placebo Controlled Study of the Efficacy and Safety of Three Doses of Orvepitant in Subjects With Chronic Refractory Cough
Lead sponsor
Nerre Therapeutics Ltd.
Phase
Phase 2
Overall status
Completed
Start date
May 22, 2017
Completion date
January 24, 2019
Enrollment
315 (actual)
Sites
66

Conditions

As the registry lists them; a condition with its own page is linked.

chronic refractory cough